Zuoren Yu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- RNA Interference and Gene Delivery
Papers in
-
- MicroRNA in disease regulation 36
- Cancer-related molecular mechanisms research 18
-
- Circular RNAs in diseases 15
- RNA modifications and cancer 9
- RNA Research and Splicing 9
- RNA Interference and Gene Delivery 8
- Epigenetics and DNA Methylation 7
- Co-authors
- Richard G. PestellMichael P. LisantiTimothy G. PestellNorman B. HechtChenguang WangTobias RaabeJinhui LüQian Zhao
- Journals
- Theranostics (6 papers)Scientific Reports (3 papers)Oncotarget (3 papers)Cell Death and Disease (3 papers)Frontiers in Cell and Developmental Biology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Zuoren Yu
85 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 1.7k
- Molecular Biology 2.7k
- Oncology 773
- Reproductive Medicine 225
- Immunology 323
Countries citing papers authored by Zuoren Yu
This map shows the geographic impact of Zuoren Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoren Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoren Yu more than expected).
Fields of papers citing papers by Zuoren Yu
This network shows the impact of papers produced by Zuoren Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoren Yu. The network helps show where Zuoren Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zuoren Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 75 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 29 | |
| 12 | 2019 | 22 | |
| 13 | 2019 | 8 | |
| 14 | 2016 | 5 | |
| 15 | 2014 | 21 | |
| 16 | 2012 | 16 | |
| 17 | 2012 | 47 | |
| 18 | 2010 | 106 | |
| 19 | 2009 | 38 | |
| 20 | 2005 | 198 |
About Zuoren Yu
Zuoren Yu is a scholar working on Cancer Research, Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine and Cell Biology, having authored 86 papers that have together received 4.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (36 papers), Cancer-related molecular mechanisms research (18 papers), Circular RNAs in diseases (15 papers), RNA modifications and cancer (9 papers), RNA Research and Splicing (9 papers), RNA Interference and Gene Delivery (8 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.7k citations), Oncology (773 citations), Reproductive Medicine (225 citations) and Immunology (323 citations). Zuoren Yu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Richard G. Pestell, Michael P. Lisanti, Timothy G. Pestell, Norman B. Hecht, Chenguang Wang, Tobias Raabe, Jinhui Lü, Qian Zhao, Min Wang and Mathew C. Casimiro. Their work appears in journals such as Theranostics, Scientific Reports, Oncotarget, Cell Death and Disease and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.